Ardelyx
ARDX
3.26
-0.05
-1.51%
Ardelyx
US · ARDX
#3380 by market cap
3.26
-0.05
-1.51%
Live - 5344 symbols - heartbeat 527s ago
· 2026-10-08 09:08
Pre-market
3.28
+0.61%
After-hours
3.28
+0.61%
Overnight
3.26
0.00%
- Market cap
- 841.69M
- P/E (TTM)i
- -14.17
- P/Bi
- 5.65
- EPSi
- -0.26
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on ARDX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.11, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +22.09% YoY
Margins
- Gross margin
- 90.29%
- Operating margin
- -10.06%
- Net margin
- -15.12%
Key ratios & quality
- Enterprise valuei
- 781.32M
- Altman Z-Scorei
- 0.11
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.61M | 5.28M | 7.57M | 10.10M | 52.16M | 124.46M | 333.62M | 407.32M |
| Gross profit | 2.14M | 4.68M | 7.43M | 9.10M | 48.04M | 106.66M | 283.06M | 367.78M |
| Selling & admin expenses | 23.72M | 24.27M | 33.15M | 72.30M | 76.60M | 134.40M | 258.69M | 337.23M |
| Research & development | 69.37M | 71.68M | 65.05M | 91.14M | 35.20M | 35.54M | 52.32M | 71.53M |
| Operating profit | -90.95M | -91.26M | -90.78M | -154.35M | -63.76M | -63.28M | -27.95M | -40.98M |
| Pretax profit | -91.29M | -94.64M | -94.31M | -158.16M | -67.20M | -65.52M | -38.87M | -60.63M |
| Tax | 4.00K | 303.00K | 2.00K | 4.00K | 8.00K | 547.00K | 266.00K | 969.00K |
| Net profit | -91.30M | -94.94M | -94.31M | -158.17M | -67.21M | -66.07M | -39.14M | -61.60M |
| Basic EPS | -2 | -1 | -1 | -2 | 0 | 0 | 0 | 0 |
| Diluted EPS | -1.62 | -1.47 | -1.05 | -1.52 | -0.42 | -0.30 | -0.17 | -0.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 74.11M | 97.66M | 110.33M | 125.22M | 94.47M | 120.88M |
| Gross profit | 61.81M | 85.26M | 106.35M | 114.37M | 89.66M | 115.12M |
| Selling & admin expenses | 83.22M | 83.99M | 83.61M | 86.41M | 102.27M | 101.44M |
| Research & development | 14.94M | 15.67M | 18.07M | 22.86M | 20.19M | 26.10M |
| Operating profit | -36.35M | -14.40M | 4.67M | 5.10M | -32.79M | -12.43M |
| Pretax profit | -40.29M | -19.08M | -867.00K | -400.00K | -37.60M | -16.61M |
| Tax | 859.00K | 1.00K | 102.00K | 7.00K | 8.00K | 110.00K |
| Net profit | -41.14M | -19.08M | -969.00K | -407.00K | -37.61M | -16.72M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.17 | -0.08 | 0.00 | 0.00 | -0.15 | -0.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 176.37M | 252.06M | 194.69M | 133.65M | 153.60M | 246.11M | 356.45M | 382.32M |
| Cash & ST investments | 168.09M | 247.51M | 186.48M | 116.69M | 123.91M | 184.30M | 250.10M | 264.69M |
| Inventory | -- | -- | -- | 0 | 3.28M | 12.45M | 21.17M | 17.74M |
| Total assets | 183.33M | 259.78M | 201.56M | 149.91M | 190.07M | 297.58M | 435.75M | 501.60M |
| Total current liabilities | 17.73M | 22.22M | 28.42M | 52.82M | 65.60M | 50.39M | 77.83M | 88.61M |
| Short-term debt | -- | 3.79M | 6.28M | 35.76M | 30.61M | 4.44M | 1.56M | 1.48M |
| Long-term debt | 49.21M | 48.83M | 46.62M | -- | -- | 49.82M | 150.85M | 202.83M |
| Total liabilities | 67,519,000.00 | 73,127,000.00 | 75,450,000.00 | 67,296,000.00 | 91,737,000.00 | 130,763,000.00 | 262,465,000.00 | 334,655,000.00 |
| Total equity | 115.81M | 186.66M | 126.11M | 82.62M | 98.33M | 166.82M | 173.29M | 166.95M |
| Retained earnings | -365.51M | -460.45M | -554.77M | -712.93M | -780.14M | -846.20M | -885.34M | -946.94M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 312.69M | 351.57M | 367.99M | 382.32M | 381.87M | 441.93M |
| Cash & ST investments | 213.95M | 238.45M | 242.71M | 264.69M | 238.07M | 281.83M |
| Inventory | 23.78M | 22.28M | 25.17M | 17.74M | 22.75M | 25.86M |
| Total assets | 410.19M | 466.77M | 486.17M | 501.60M | 504.51M | 575.89M |
| Total current liabilities | 75.84M | 81.72M | 83.39M | 88.61M | 109.57M | 132.22M |
| Short-term debt | 1.30M | 1.18M | 1.44M | 1.48M | 1.51M | 1.55M |
| Long-term debt | 151.30M | 201.45M | 202.14M | 202.83M | 203.52M | 251.82M |
| Total liabilities | 264,518,000.00 | 327,239,000.00 | 331,890,000.00 | 334,655,000.00 | 355,885,000.00 | 426,881,000.00 |
| Total equity | 145.68M | 139.53M | 154.28M | 166.95M | 148.62M | 149.01M |
| Retained earnings | -926.48M | -945.56M | -946.53M | -946.94M | -984.54M | -1.00B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -70.27M | -76.48M | -81.44M | -152.55M | -70.04M | -89.72M | -44.81M | -42.48M |
| Depreciation & amortization | 2.68M | 2.50M | 2.54M | 2.81M | 1.14M | 1.29M | 2.06M | 3.06M |
| Free cash flow | -70.59M | -76.81M | -81.76M | -154.42M | -70.10M | -90.06M | -45.82M | -43.98M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 53.77M | 154.90M | 21.05M | 101.15M | 71.63M | 119.24M | 0 | 0 |
| Ending cash balance | 78.77M | 181.13M | 91.03M | 72.43M | 96.14M | 21.47M | 64.93M | 68.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -38.46M | -25.34M | 365.00K | 20.95M | -32.24M | -6.40M |
| Depreciation & amortization | 602.00K | 631.00K | 905.00K | 921.00K | 915.00K | 604.00K |
| Free cash flow | -38.78M | -25.99M | 209.00K | 20.59M | -32.31M | -6.41M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 30.81M | 90.05M | 42.72M | 68.00M | 31.21M | 97.19M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -71.57 | -62.78 | -60.31 | -151.55 | -74.28 | -49.83 | -23.01 | -36.21 |
| ROA %i | -53.51 | -42.85 | -40.89 | -90.00 | -39.54 | -27.10 | -10.67 | -13.14 |
| ROIC %i | -50.19 | -44.26 | -43.06 | -100.72 | -48.08 | -33.03 | -8.47 | -11.16 |
| 5-year avg ROE %i | -- | -56.48 | -61.56 | -76.98 | -84.10 | -79.75 | -71.80 | -66.98 |
| EBIT margin %i | -3,366.32 | -1,683.60 | -1,178.34 | -1,521.83 | -119.11 | -45.51 | -5.63 | -7.91 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 9.95 | 11.34 | 6.85 | 2.53 | 2.34 | 4.88 | 4.58 | 4.31 |
| Quick ratioi | 9.77 | 11.17 | 6.56 | 2.22 | 2.01 | 4.09 | 3.95 | 3.80 |
| Debt / assetsi | 26.84 | 21.06 | 26.45 | 30.35 | 19.18 | 18.81 | 35.21 | 41.46 |
| LT debt / equityi | 42.49 | 27.27 | 37.30 | 11.80 | 5.95 | 30.90 | 87.64 | 123.68 |
| Interest coveragei | -24.83 | -15.53 | -17.50 | -34.13 | -12.25 | -6.38 | -0.93 | -1.14 |
| Revenue CAGR (3Y) %i | -52.30 | -- | -43.51 | 57.04 | 114.55 | 154.27 | 220.89 | 98.40 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -36.26 | -39.36 | -36.18 | -36.21 | -39.46 | -38.61 |
| ROA %i | -14.29 | -13.92 | -13.24 | -13.14 | -12.69 | -10.68 |
| ROIC %i | -12.99 | -12.52 | -11.36 | -11.16 | -12.36 | -10.24 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -8.42 | -8.15 | -7.25 | -7.91 | -6.76 | -5.94 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.12 | 4.30 | 4.41 | 4.31 | 3.49 | 3.34 |
| Quick ratioi | 3.43 | 3.68 | 3.83 | 3.80 | 2.93 | 2.89 |
| Debt / assetsi | 37.81 | 44.27 | 42.70 | 41.46 | 41.28 | 44.49 |
| LT debt / equityi | 105.58 | 147.25 | 133.64 | 123.68 | 139.11 | 170.89 |
| Interest coveragei | -1.37 | -1.31 | -1.08 | -1.14 | -0.99 | -0.93 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product sales, net is the largest reported line at 97.73% of revenue, across 2 reported segments.
- The next-largest line, Other revenues, is a distant second at 2.27% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product sales, net97.73%
Other revenues2.27%
Quote time 2026-10-08 09:08:39 · For reference only, not investment advice and not tailored to your situation.